Computational research needs lab experimental validations to confirm that the predicted antibodies bind effectively to the target antigens, which is expensive. This step will be crucial to ensure that the monoclonal antibodies perform as expected in human biological systems. In future research, I plan to conduct lab experiments like ELISA, a widely used method for verifying the binding of antibodies to proteins. Furthermore, in this research, I have used a limited number of antibodies for analysis. This limited selection can limit the diversity of possible outcomes. In future research, I plan on exploring a much more comprehensive and varied range of possible antibody options to enhance the scope and precision of our findings, improving the chances of identifying the most effective candidate. I have yet to explore the binding of antibodies to other proteins. I